{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:44:12Z","timestamp":1747183452484,"version":"3.40.5"},"reference-count":30,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1111\/bcp.14353","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T03:53:20Z","timestamp":1588910000000},"page":"1790-1792","source":"Crossref","is-referenced-by-count":4,"title":["Chronic myeloid leukaemia and the use of tyrosine kinase inhibitors in the days of COVID\u201019 pandemic"],"prefix":"10.1111","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-0894","authenticated-orcid":false,"given":"Ahmet Emre","family":"E\u015fkazan","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine Istanbul University\u2010Cerrahpasa  Istanbul Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13637"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30096-6"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1339599"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13933"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14092"},{"key":"e_1_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjh.2012-0015"},{"key":"e_1_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.040048"},{"key":"e_1_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13508"},{"key":"e_1_2_3_12_1","doi-asserted-by":"crossref","unstructured":"Dan\u2010YuW Jing\u2010MingG Zhuang\u2010ZhiY et al.The first report of the prevalence of COVID\u201019 in Chronic myelogenous leukemia patients in the core epidemic area of China: multicentre cross\u2010sectional survey. medRxiv 2020.03.12.20034876; doi:https:\/\/doi.org\/10.1101\/2020.03.12.20034876","DOI":"10.1101\/2020.03.12.20034876"},{"key":"e_1_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-018-0270-x"},{"key":"e_1_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70579-5"},{"key":"e_1_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-018-3413-7"},{"key":"e_1_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12496"},{"key":"e_1_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294330"},{"key":"e_1_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.6.748"},{"key":"e_1_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39402"},{"key":"e_1_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03150.x"},{"key":"e_1_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200528"},{"key":"e_1_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0700-9"},{"key":"e_1_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0796-y"},{"key":"e_1_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0050-x"},{"key":"e_1_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.104"},{"issue":"5","key":"e_1_2_3_26_1","first-page":"795","article-title":"Chloroquine and QTc interval","volume":"25","author":"Silva JA","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1310\/hpj5110-830"},{"key":"e_1_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2020.01012"},{"key":"e_1_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006034"},{"key":"e_1_2_3_30_1","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) v5.0.https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf"},{"key":"e_1_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00097"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.14353","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14353","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14353","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T22:52:08Z","timestamp":1693867928000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1111\/bcp.14353"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14353","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"type":"print","value":"0306-5251"},{"type":"electronic","value":"1365-2125"}],"subject":[],"published":{"date-parts":[[2020,5,20]]}}}